-
2023-509572-42-00
3
2024-07-17
Lung Cancer
-
2023-507641-29-00
4
2024-07-15
Locally Advanced or Metastatic Solid Tumors
-
2024-515235-29-00
4
2024-07-09
Reconstructive skin surgery in basal cell cancer (Mohs surgery).
-
2023-510536-37-00
4
2024-07-05
Prostate Cancer
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-511959-18-01
5
2024-07-01
Acute Pulmonary Embolism
-
2022-502404-73-00
4
2024-06-03
Pancreatic ductal adenocarcinoma
-
2023-507751-30-00
9
2024-05-27
relapsed or refractory multiple myeloma
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2022-501590-39-00
1
2024-05-22
Solid Tumor
-
2023-503631-18-01
5
2024-05-20
Nervous system diseases
-
2023-509204-15-00
4
2024-05-17
Metastatic colorectal cancer
-
2023-504151-27-00
5
2024-05-09
Psychosis associated with Alzheimer’s Disease
-
2022-502276-23-00
5
2024-04-25
JAK2V617F-positive high-risk Polycythemia Vera
-
2022-502576-23-00
1
2024-04-17
Platinum-resistant recurrent (PRR) ovarian cancer, Platinum-sensitive
-
2023-504865-21-00
5
2024-04-15
Essential Thrombocythemia patients who have an inadequate response to
-
2023-508442-18-00
5
2024-04-14
Patients with an infection of the osteosynthesis material implanted af
-
2023-507293-40-00
6
2024-04-11
VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA
-
2023-503208-94-00
6
2024-04-04
Prostate cancer
-
2023-504923-20-00
5
2024-04-04
Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2023-506759-51-00
7
2024-03-29
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-504031-41-00
5
2024-03-25
ER+/HER2- Early Breast Cancer
-
2023-503376-24-00
5
2024-03-20
Metastatic non-small cell lung cancer (NSCLC)